Acasti Pharma Inc. (ACST) |
| 3.37 0.13 (4.01%) 10-25 16:00 |
| Open: | 3.4268 |
| High: | 3.448 |
| Low: | 3.2 |
| Volume: | 27,682 |
| Market Cap: | 34(M) |
| PE Ratio: | -2.36 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 3.6 |
| 52w Low: | 1.98 |
Acasti Pharma Inc. operates as a biopharmaceutical firm, concentrating its efforts on developing and marketing pharmaceutical solutions specifically for cardiovascular conditions. The company is currently exploring potential strategic alliances to further the clinical development of its drug candidate, CaPre. This Canadian company, which was established in 2002, has its main offices located in Laval.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 24 Apr 2025
Acasti Pharma (ACST) Stock Price, News & Analysis - Stock Titan
Fri, 25 Oct 2024
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - Yahoo Finance
Fri, 07 May 2021
Acasti Pharma To Acquire Grace Therapeutics: Highlights - Yahoo Finance
Mon, 13 Jan 2020
Amarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall Short - Barron's
Wed, 15 Nov 2017
Acasti Pharma (ACST-Q) Stock Price and News - The Globe and Mail
Tue, 28 Jul 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
